118 related articles for article (PubMed ID: 38901567)
1. Clinical significance of LINC02532 in hepatitis B virus-associated hepatocellular carcinoma and its regulatory effect on tumor progression.
Ding W; Xi S; Gao K; Weng D; Xu S; Huang G; Yu M; Yue H; Wang J
Clin Res Hepatol Gastroenterol; 2024 Jun; ():102403. PubMed ID: 38901567
[TBL] [Abstract][Full Text] [Related]
2. Potentials as biomarker and therapeutic target of upregulated long non-coding RNA HLA-F antisense RNA 1 in hepatitis B virus-associated hepatocellular carcinoma.
Zhang X; Li W; Li S; Zhang Z; Song W
Virus Genes; 2024 Jun; 60(3):243-250. PubMed ID: 38568442
[TBL] [Abstract][Full Text] [Related]
3. Role of microRNA-210-3p in hepatitis B virus-related hepatocellular carcinoma.
Morishita A; Fujita K; Iwama H; Chiyo T; Fujihara S; Oura K; Tadokoro T; Mimura S; Nomura T; Tani J; Yoneyama H; Kobayashi K; Kamada H; Guan Y; Nishiyama A; Okano K; Suzuki Y; Himoto T; Shimotohno K; Masaki T
Am J Physiol Gastrointest Liver Physiol; 2020 Mar; 318(3):G401-G409. PubMed ID: 31905024
[TBL] [Abstract][Full Text] [Related]
4. Long non-coding RNA F11-AS1 inhibits HBV-related hepatocellular carcinoma progression by regulating NR1I3 via binding to microRNA-211-5p.
Deng Y; Wei Z; Huang M; Xu G; Wei W; Peng B; Nong S; Qin H
J Cell Mol Med; 2020 Jan; 24(2):1848-1865. PubMed ID: 31880390
[TBL] [Abstract][Full Text] [Related]
5. miR-106b promotes cancer progression in hepatitis B virus-associated hepatocellular carcinoma.
Yen CS; Su ZR; Lee YP; Liu IT; Yen CJ
World J Gastroenterol; 2016 Jun; 22(22):5183-92. PubMed ID: 27298561
[TBL] [Abstract][Full Text] [Related]
6. Clinical Value Evaluation of microRNA-324-3p and Other Available Biomarkers in Patients With HBV Infection-Related Hepatocellular Carcinoma.
Zhao L; Yang Q; Liu J
Open Forum Infect Dis; 2021 Jun; 8(6):ofab108. PubMed ID: 34189151
[TBL] [Abstract][Full Text] [Related]
7. Expression profile of altered long non-coding RNAs in patients with HBV-associated hepatocellular carcinoma.
Pan YF; Qin T; Feng L; Yu ZJ
J Huazhong Univ Sci Technolog Med Sci; 2013 Feb; 33(1):96-101. PubMed ID: 23392715
[TBL] [Abstract][Full Text] [Related]
8. Identification of long noncoding RNAs biomarkers in patients with hepatitis B virus-associated hepatocellular carcinoma.
Mou Y; Wang D; Xing R; Nie H; Mou Y; Zhang Y; Zhou X
Cancer Biomark; 2018; 23(1):95-106. PubMed ID: 29991128
[TBL] [Abstract][Full Text] [Related]
9. LINC02532 Contributes to Radiosensitivity in Clear Cell Renal Cell Carcinoma through the miR-654-5p/YY1 Axis.
Zhou X; Zeng B; Li Y; Wang H; Zhang X
Molecules; 2021 Nov; 26(22):. PubMed ID: 34834139
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of serum miR-768-3p in HBV-related hepatocellular carcinoma and its potential mechanism.
Cao C; Wang C
Clin Exp Med; 2020 Nov; 20(4):569-576. PubMed ID: 32712720
[TBL] [Abstract][Full Text] [Related]
11. LINC02532 by Mediating miR-541-3p/HMGA1 Axis Exerts a Tumor Promoter in Breast cancer.
Zhao C; Li X; Pan X; Xu J; Jiang R; Li Y
Mol Biotechnol; 2023 Nov; ():. PubMed ID: 38030946
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-325-3p inhibits cell proliferation and induces apoptosis in hepatitis B virus-related hepatocellular carcinoma by down-regulation of aquaporin 5.
Zhang Z; Han Y; Sun G; Liu X; Jia X; Yu X
Cell Mol Biol Lett; 2019; 24():13. PubMed ID: 30805015
[TBL] [Abstract][Full Text] [Related]
13. Aberrant expression of two miRNAs promotes proliferation, hepatitis B virus amplification, migration and invasion of hepatocellular carcinoma cells: evidence from bioinformatic analysis and experimental validation.
Liu Y; Cao Y; Cai W; Wu L; Zhao P; Liu XG
PeerJ; 2020; 8():e9100. PubMed ID: 32377460
[TBL] [Abstract][Full Text] [Related]
14. Novel long non-coding RNA LINC02532 promotes gastric cancer cell proliferation, migration, and invasion
Zhang C; Ma MH; Liang Y; Wu KZ; Dai DQ
World J Gastrointest Oncol; 2019 Feb; 11(2):91-101. PubMed ID: 30788037
[TBL] [Abstract][Full Text] [Related]
15. Elevated LINC01232 is associated with poor prognosis and HBV infection in hepatocellular carcinoma patients and contributes to tumor progression in vitro.
Guo L; Gao S; Sun W; Wang Y; Zhao J
Clin Res Hepatol Gastroenterol; 2022 Mar; 46(3):101813. PubMed ID: 34583064
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic and prognostic roles of circulating miRNA-223-3p in hepatitis B virus-related hepatocellular carcinoma.
Pratedrat P; Chuaypen N; Nimsamer P; Payungporn S; Pinjaroen N; Sirichindakul B; Tangkijvanich P
PLoS One; 2020; 15(4):e0232211. PubMed ID: 32330203
[TBL] [Abstract][Full Text] [Related]
17. Etiologically Significant microRNAs in Hepatitis B Virus-Induced Hepatocellular Carcinoma.
Ramakrishnan K; Vishwakarma R; Dev RR; Raju R; Rehman N
OMICS; 2024 Jun; 28(6):280-290. PubMed ID: 38818956
[TBL] [Abstract][Full Text] [Related]
18. The miR-545/374a cluster encoded in the Ftx lncRNA is overexpressed in HBV-related hepatocellular carcinoma and promotes tumorigenesis and tumor progression.
Zhao Q; Li T; Qi J; Liu J; Qin C
PLoS One; 2014; 9(10):e109782. PubMed ID: 25299640
[TBL] [Abstract][Full Text] [Related]
19. Upregulated in Hepatitis B virus-associated hepatocellular carcinoma cells, miR-331-3p promotes proliferation of hepatocellular carcinoma cells by targeting ING5.
Cao Y; Chen J; Wang D; Peng H; Tan X; Xiong D; Huang A; Tang H
Oncotarget; 2015 Nov; 6(35):38093-106. PubMed ID: 26497554
[TBL] [Abstract][Full Text] [Related]
20. MiR-222-3p induced by hepatitis B virus promotes the proliferation and inhibits apoptosis in hepatocellular carcinoma by upregulating THBS1.
Sun Y; Shi P; Wu Q; Liu B; Yu Z; Jia H; Chang H
Hum Cell; 2021 Nov; 34(6):1788-1799. PubMed ID: 34273068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
